Status:

COMPLETED

Telemedicine Monitoring of Nocturnal Incidents

Lead Sponsor:

University of Southern California

Conditions:

Diabetes Mellitus, Type 1

Hypoglycemia

Eligibility:

All Genders

65+ years

Phase:

NA

Brief Summary

Reducing hypoglycemia is an important aspect of management of type 1 diabetes (T1D) in older adults, many of whom have hypoglycemic unawareness, cognitive impairment, or both. Continuous Glucose Monit...

Detailed Description

SUMMARY OF STUDY RATIONAL - Reducing hypoglycemia is an important aspect of management of T1D in older adults, many of whom have hypoglycemic unawareness, cognitive impairment, or both. CGM offers the...

Eligibility Criteria

Inclusion

  • Diagnosis of type 1 diabetes
  • Age \>65 years old
  • Insulin regimen involves either use of an insulin pump or multiple daily injections of insulin.
  • Understand the study requirements and agree to comply with all study visits and procedures, including the use of the study CGM.
  • Fluent in English or Spanish
  • Must have a smart phone

Exclusion

  • 1\) No serious illnesses where life expectancy is \<1 year
  • \-

Key Trial Info

Start Date :

June 15 2018

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

November 30 2018

Estimated Enrollment :

10 Patients enrolled

Trial Details

Trial ID

NCT04328896

Start Date

June 15 2018

End Date

November 30 2018

Last Update

April 1 2020

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

USC Westside Center for Diabetes

Los Angeles, California, United States, 90211